These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22142375)

  • 1. Severe acute liver injury associated with lumiracoxib.
    Pillans PI; Ghiculescu RA; Lampe G; Wilson R; Wong R; Macdonald GA
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1102-5. PubMed ID: 22142375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.
    Farkouh ME; Greenberg JD; Jeger RV; Ramanathan K; Verheugt FW; Chesebro JH; Kirshner H; Hochman JS; Lay CL; Ruland S; Mellein B; Matchaba PT; Fuster V; Abramson SB
    Ann Rheum Dis; 2007 Jun; 66(6):764-70. PubMed ID: 17412741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumiracoxib in the management of osteoarthritis and acute pain.
    Bannwarth B; Bérenbaum F
    Expert Opin Pharmacother; 2007 Jul; 8(10):1551-64. PubMed ID: 17661736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lumiracoxib taken off the market in Australia. What does that mean for our patients? (interview by Dr. Judith Neumaier)].
    Brune K
    MMW Fortschr Med; 2007 Sep; 149(39):6. PubMed ID: 17987737
    [No Abstract]   [Full Text] [Related]  

  • 5. Lessons from Lumiracoxib: are cyclooxygenase-2 inhibitors less hepatotoxic than non-selective non-steroidal anti-inflammatory drugs?
    Chitturi S; Farrell GC
    J Gastroenterol Hepatol; 2012 Jun; 27(6):993-4. PubMed ID: 22621454
    [No Abstract]   [Full Text] [Related]  

  • 6. Lumiracoxib-induced cholestatic liver injury.
    Fok KC; Bell CJ; Read RB; Eckstein RP; Jones BE
    Intern Med J; 2013 Jun; 43(6):731-2. PubMed ID: 23745998
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study.
    Hawkey CJ; Weinstein WM; Smalley W; Gitton X; Sallstig P; Stricker K; Krammer G; Mellein B; Richard D; Matchaba P
    Gastroenterology; 2007 Jul; 133(1):57-64. PubMed ID: 17631131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on blood pressure of lumiracoxib versus ibuprofen in patients with osteoarthritis and controlled hypertension: a randomized trial.
    MacDonald TM; Reginster JY; Littlejohn TW; Richard D; Lheritier K; Krammer G; Rebuli R
    J Hypertens; 2008 Aug; 26(8):1695-702. PubMed ID: 18622250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis.
    Matchaba P; Gitton X; Krammer G; Ehrsam E; Sloan VS; Olson M; Mellein B; Hoexter G; Orloff J; Garaud JJ
    Clin Ther; 2005 Aug; 27(8):1196-214. PubMed ID: 16199245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised, double-blind study comparing lumiracoxib with naproxen for acute musculoskeletal pain.
    Kyle C; Zachariah J; Kinch H; Ellis G; Andrews C; Adekunle F
    Int J Clin Pract; 2008 Nov; 62(11):1684-92. PubMed ID: 19143855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis.
    Mackenzie IS; Wei L; Macdonald TM
    Eur J Clin Pharmacol; 2013 Feb; 69(2):133-41. PubMed ID: 22732767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lumiracoxib--Prexigem].
    Duh D; Vandevijver A
    J Pharm Belg; 2007; 62(3):95-6. PubMed ID: 17955960
    [No Abstract]   [Full Text] [Related]  

  • 13. Lumiracoxib.
    Buvanendran A; Barkin R
    Drugs Today (Barc); 2007 Mar; 43(3):137-47. PubMed ID: 17380211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 selective inhibitors in the treatment of osteoarthritis.
    Laine L; White WB; Rostom A; Hochberg M
    Semin Arthritis Rheum; 2008 Dec; 38(3):165-87. PubMed ID: 18177922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lumiracoxib for acute postoperative dental pain: a systematic review of randomized clinical trials.
    Silva RC; Riera R; Saconato H
    Sao Paulo Med J; 2011; 129(5):335-45. PubMed ID: 22069133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.
    Farkouh ME; Kirshner H; Harrington RA; Ruland S; Verheugt FW; Schnitzer TJ; Burmester GR; Mysler E; Hochberg MC; Doherty M; Ehrsam E; Gitton X; Krammer G; Mellein B; Gimona A; Matchaba P; Hawkey CJ; Chesebro JH;
    Lancet; 2004 Aug 21-27; 364(9435):675-84. PubMed ID: 15325832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of takotsubo cardiomyopathy precipitated by lumiracoxib, a selective COX-2 inhibitor.
    Ker J; Van Wyk CJ
    Cardiovasc J Afr; 2007; 18(6):383-4. PubMed ID: 18092115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversible hepatitis associated with diclofenac.
    Ouellette GS; Slitzky BE; Gates JA; Lagarde S; West AB
    J Clin Gastroenterol; 1991 Apr; 13(2):205-10. PubMed ID: 2033230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib - study design and patient demographics.
    Hawkey CJ; Farkouh M; Gitton X; Ehrsam E; Huels J; Richardson P
    Aliment Pharmacol Ther; 2004 Jul; 20(1):51-63. PubMed ID: 15225171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
    Sheldon E; Beaulieu A; Paster Z; Dutta D; Yu S; Sloan VS
    Clin Ther; 2005 Jan; 27(1):64-77. PubMed ID: 15763607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.